185 related articles for article (PubMed ID: 37838774)
41. CART cells are prone to Fas- and DR5-mediated cell death.
Tschumi BO; Dumauthioz N; Marti B; Zhang L; Lanitis E; Irving M; Schneider P; Mach JP; Coukos G; Romero P; Donda A
J Immunother Cancer; 2018 Jul; 6(1):71. PubMed ID: 30005714
[TBL] [Abstract][Full Text] [Related]
42. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
43. The role of the Fas/FasL signaling pathway in environmental toxicant-induced testicular cell apoptosis: An update.
Wang M; Su P
Syst Biol Reprod Med; 2018 Apr; 64(2):93-102. PubMed ID: 29299971
[TBL] [Abstract][Full Text] [Related]
44. Cadmium-induced apoptosis in neuronal cells is mediated by Fas/FasL-mediated mitochondrial apoptotic signaling pathway.
Yuan Y; Zhang Y; Zhao S; Chen J; Yang J; Wang T; Zou H; Wang Y; Gu J; Liu X; Bian J; Liu Z
Sci Rep; 2018 Jun; 8(1):8837. PubMed ID: 29891925
[TBL] [Abstract][Full Text] [Related]
45. Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack.
O'Connell J; Bennett MW; O'Sullivan GC; Collins JK; Shanahan F
Dis Esophagus; 1999; 12(2):83-9. PubMed ID: 10466039
[TBL] [Abstract][Full Text] [Related]
46. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand.
Knox PG; Milner AE; Green NK; Eliopoulos AG; Young LS
J Immunol; 2003 Jan; 170(2):677-85. PubMed ID: 12517928
[TBL] [Abstract][Full Text] [Related]
48. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia.
Ortiz-Arduan A; Danoff TM; Kalluri R; González-Cuadrado S; Karp SL; Elkon K; Egido J; Neilson EG
Am J Physiol; 1996 Dec; 271(6 Pt 2):F1193-201. PubMed ID: 8997393
[TBL] [Abstract][Full Text] [Related]
49. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
[TBL] [Abstract][Full Text] [Related]
50. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
51. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
[TBL] [Abstract][Full Text] [Related]
52. The Btk-dependent PIP5K1γ lipid kinase activation by Fas counteracts FasL-induced cell death.
Rossin A; Lounnas N; Durivault J; Miloro G; Gagnoux-Palacios L; Hueber AO
Apoptosis; 2017 Nov; 22(11):1344-1352. PubMed ID: 28879546
[TBL] [Abstract][Full Text] [Related]
53. Gene therapy for human ovarian cancer cells using efficient expression of Fas gene combined with γδT cells.
Lin J; Zeng D; He H; Tan G; Lan Y; Jiang F; Sheng S
Mol Med Rep; 2017 Oct; 16(4):3791-3798. PubMed ID: 28765933
[TBL] [Abstract][Full Text] [Related]
54. Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression.
Contassot E; Kerl K; Roques S; Shane R; Gaide O; Dupuis M; Rook AH; French LE
Blood; 2008 May; 111(9):4780-7. PubMed ID: 18314443
[TBL] [Abstract][Full Text] [Related]
55. Fas receptor (CD95)-mediated apoptosis in leukemic cells.
Komada Y; Sakurai M
Leuk Lymphoma; 1997 Mar; 25(1-2):9-21. PubMed ID: 9130610
[TBL] [Abstract][Full Text] [Related]
56. Surfactant protein D delays Fas- and TRAIL-mediated extrinsic pathway of apoptosis in T cells.
Djiadeu P; Kotra LP; Sweezey N; Palaniyar N
Apoptosis; 2017 May; 22(5):730-740. PubMed ID: 28168327
[TBL] [Abstract][Full Text] [Related]
57. Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes.
Mateo V; Ménager M; de Saint-Basile G; Stolzenberg MC; Roquelaure B; André N; Florkin B; le Deist F; Picard C; Fischer A; Rieux-Laucat F
Blood; 2007 Dec; 110(13):4285-92. PubMed ID: 17724145
[TBL] [Abstract][Full Text] [Related]
58. Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways.
Das T; Sa G; Paszkiewicz-Kozik E; Hilston C; Molto L; Rayman P; Kudo D; Biswas K; Bukowski RM; Finke JH; Tannenbaum CS
J Immunol; 2008 Apr; 180(7):4687-96. PubMed ID: 18354192
[TBL] [Abstract][Full Text] [Related]
59. Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes.
Nakayama M; Nagata M; Yasuda H; Arisawa K; Kotani R; Yamada K; Chowdhury SA; Chakrabarty S; Jin ZZ; Yagita H; Yokono K; Kasuga M
Diabetes; 2002 May; 51(5):1391-7. PubMed ID: 11978635
[TBL] [Abstract][Full Text] [Related]
60. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
